|
|
(Natural News) Axios and Public Citizen have obtained new documents suggesting that the National Institutes of Health (NIH) owns half of the key patent on Moderna’s up-and-coming vaccine for the Wuhan coronavirus (COVID-19). Should the vaccine come to market, the NIH will reportedly collect half of the royalties associated with its distribution. At the same… |